ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01605318
Recruitment Status : Active, not recruiting
First Posted : May 24, 2012
Last Update Posted : November 14, 2018
Sponsor:
Information provided by (Responsible Party):
Immunomedics, Inc.